• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Editorial Staff
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
The Medical Journal of Cairo University
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 88 (2020)
Issue December
Issue September
Issue June
Issue March
Volume Volume 87 (2019)
Volume Volume 86 (2018)
MOHEBAT H. GOUDA, M.D., M., NEHAL S. ZAFER, M.D., T., ELBAZ, M.D., M. (2020). Chromophobe Renal Cell Carcinoma, Oncocytoma and Clear Cell Carcinoma: A Compartive Immunohistochemical Study. The Medical Journal of Cairo University, 88(March), 103-110. doi: 10.21608/mjcu.2020.93966
MOHAMMED ABD ELHAMID, M.Sc.; MOHEBAT H. GOUDA, M.D.; TAGHREED ABD ELSAMEE, M.D.; NEHAL S. ZAFER, M.D.; MAHMMOUD ELBAZ, M.D.. "Chromophobe Renal Cell Carcinoma, Oncocytoma and Clear Cell Carcinoma: A Compartive Immunohistochemical Study". The Medical Journal of Cairo University, 88, March, 2020, 103-110. doi: 10.21608/mjcu.2020.93966
MOHEBAT H. GOUDA, M.D., M., NEHAL S. ZAFER, M.D., T., ELBAZ, M.D., M. (2020). 'Chromophobe Renal Cell Carcinoma, Oncocytoma and Clear Cell Carcinoma: A Compartive Immunohistochemical Study', The Medical Journal of Cairo University, 88(March), pp. 103-110. doi: 10.21608/mjcu.2020.93966
MOHEBAT H. GOUDA, M.D., M., NEHAL S. ZAFER, M.D., T., ELBAZ, M.D., M. Chromophobe Renal Cell Carcinoma, Oncocytoma and Clear Cell Carcinoma: A Compartive Immunohistochemical Study. The Medical Journal of Cairo University, 2020; 88(March): 103-110. doi: 10.21608/mjcu.2020.93966

Chromophobe Renal Cell Carcinoma, Oncocytoma and Clear Cell Carcinoma: A Compartive Immunohistochemical Study

Article 14, Volume 88, March, March 2020, Page 103-110  XML PDF (897.96 K)
Document Type: Original Article
DOI: 10.21608/mjcu.2020.93966
Authors
MOHAMMED ABD ELHAMID, M.Sc.; MOHEBAT H. GOUDA, M.D.; TAGHREED ABD ELSAMEE, M.D.; NEHAL S. ZAFER, M.D.; MAHMMOUD ELBAZ, M.D.
The Department of Pathology, Faculty of Medicine, Benha University* and Department of Pathology, Urology & Nephrology Center, Mansoura University**
Abstract
Abstract Background: Renal oncocytoma, chromophobe RCC, and conventional RCC (granular cell type) have different prognosis. The differentiation between them sometimes is difficult and may cause a diagnostic dilemma. Aim of Study: To reveal the better immunohistochemical diagnostic markers for differentiation between Chromophobe Renal Cell Carcinoma (ChRCC), Clear Cell Renal Cell Car-cinoma (CCRCC), and oncocytoma. Material and Methods: We reviewed one hundred and fifty cases of renal cell carcinoma: ChRCC (100 case), CCRCC (25 cases) and RO (25 cases). We carried out comprehensive immunohistochemical profiling using Hales Colloidal Iron stain (HCI), and 6 markers: Vimentin, CK7, CD 10, CD 117. EpCAM, and S100. Results: Our results demonstrated a statistically significant difference in the expression of Hales colloidal iron among the studied renal tumors (p-value <0.0001) as 94% of cases of chromophobe renal cells carcinoma showed positive staining for Hales colloidal iron, but cases of clear cell renal cell carcinoma and oncocytoma showed no staining for Hales colloidal iron stain. All cases of ChRCC were negative for vimentin. 72% of CCRCC and 8% of oncocytoma showed cytoplasmic positivity for vimentin. This difference in the expression was statistically significant (p-value <0.0001). 76% of ChRCC cases showed cytoplasmic immunoreactivity to CK7, while 8% of CCRCC and 4% of oncocytoma showed such cytoplasmic immunoreactivity for CK7. These results were statistically significant with p-value <0.0001. We found that CD 10 showed statistically significant correlation with tumour type with p-value 0.025. CD 117, EpCAM, S100A1 showed statistically significant correlation with tumor type with p-value <0.0001. Conclusion: We concluded that the best panel of markers that can differentiate between the three studied renal tumour types by calculating sensitivity and specificity of each marker in each tumour type we found that the best panel is Vimentin, EpCAM and S100A1.
Keywords
CD1 0; CK7; Chromophobe renal cell carcinoma; Clear cell renal cell carcinoma; CCRCC; S100A1; EpCAM; Immunohistochemistry; Renal oncocytoma; Vimentin
Statistics
Article View: 71
PDF Download: 79
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.